HomeCompareDVND vs JNJ

DVND vs JNJ: Dividend Comparison 2026

DVND yields 1.53% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DVND wins by $1.9K in total portfolio value
10 years
DVND
DVND
● Live price
1.53%
Share price
$34.69
Annual div
$0.53
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.9K
Annual income
$168.56
Full DVND calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DVND vs JNJ

📍 DVND pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDVNDJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DVND + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DVND pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DVND
Annual income on $10K today (after 15% tax)
$129.78/yr
After 10yr DRIP, annual income (after tax)
$143.28/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $560.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DVND + JNJ for your $10,000?

DVND: 50%JNJ: 50%
100% JNJ50/50100% DVND
Portfolio after 10yr
$21.0K
Annual income
$498.17/yr
Blended yield
2.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DVND
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DVND buys
0
JNJ buys
0
No recent congressional trades found for DVND or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDVNDJNJ
Forward yield1.53%3.36%
Annual dividend / share$0.53$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$21.9K$20.0K
Annual income after 10y$168.56$827.78
Total dividends collected$1.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DVND vs JNJ ($10,000, DRIP)

YearDVND PortfolioDVND Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,853$152.69$10,676$355.77+$177.00DVND
2$11,767$154.87$11,407$389.39+$360.00DVND
3$12,748$156.93$12,198$426.53+$550.00DVND
4$13,799$158.89$13,056$467.62+$743.00DVND
5$14,926$160.74$13,987$513.12+$939.00DVND
6$16,133$162.49$14,998$563.56+$1.1KDVND
7$17,427$164.14$16,098$619.52+$1.3KDVND
8$18,812$165.70$17,295$681.69+$1.5KDVND
9$20,296$167.17$18,599$750.82+$1.7KDVND
10$21,885$168.56$20,022$827.78+$1.9KDVND

DVND vs JNJ: Complete Analysis 2026

DVNDStock

The fund invests, under normal market conditions, at least 80% of its assets in equity securities of U.S. large-cap companies that have historically paid dividends. These securities may be listed on an exchange or traded over-the-counter. The fund may, at times, hold fewer securities and a higher percentage of cash and cash equivalents when, among other reasons, the Sub-Advisor cannot find a sufficient number of securities that meets its purchase requirements.

Full DVND Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DVND vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DVND vs SCHDDVND vs JEPIDVND vs ODVND vs KODVND vs MAINDVND vs ABBVDVND vs MRKDVND vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.